Financials

News Discussions Technicals Forecast Seasonals

MRSN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Mersana Therapeutics, Inc.

Total assets of MRSN for Q2 24 is 179.13 M USD, 9.70% less than the previous Q1 24. And total liabilities increased by 0.18% in Q2 24 to 170.7 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—